| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
| 2009 | Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells | Chang, J. W. C.; Hsieh, J. J.; Shen, Y. C.; Yeh, K. Y.; Wang, C. H.; Li, Y. Y.; Todd Hsu | Cancer Letters | | | |
| 2012 | Comparison of Genomic Signatures of Non-small Cell Lung Cancer Recurrence between Two Microarray Platforms | Chang, J. W. C.; Wei, N. C.; Su, H. J.; Huang, J. L.; Chen, T. C.; Wu, Y. C.; Yu, C. T.; Hou, M. M.; Hsieh, C. H.; Hsieh, J. J.; Wu, C. E.; Cheng, H. Y.; Todd Hsu ; Wang, T. H. | Anticancer Research | | | |
| 2007 | Correlation of CT-guided core needle biopsy demonstrating epidermal growth factor receptor mutations to the responses of gefitinib therapy in patients with lung adenocarcinoma who failed chemotherapy: preliminary report | Cheung, Y.; Chang, J. W. C.; Lin, G.; Hsieh, J. J.; Todd Hsu ; Lui, K. W. | Ejc Supplements | | | |
| 2015 | Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection | Wu, C. E.; Wang, C. W.; Huang, W. K.; Yang, C. T.; Wu, Y. C.; Hou, M. M.; Hsieh, C. H.; Hsieh, J. J.; Cheng, H. Y.; Todd Hsu ; Chang, J. W. C. | Japanese Journal of Clinical Oncology | | | |
| 2011 | EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN PATIENTS WITH ORAL CAVITY CANCER IN A BETEL NUT CHEWING-PREVALENT AREA | Hsieh, C. H.; Chang, J. W. C.; Hsieh, J. J.; Todd Hsu ; Huang, S. F.; Liao, C. T.; Wang, H. M. | Head and Neck-Journal for the Sciences and Specialties of the Head and Neck | | | |
| 2007 | Erlotinib response EGFR-mutant gefitinib-resistant non-small-cell lung cancer | Chang, J. W. C.; Chou, C. L.; Huang, S. F.; Wang, H. M.; Hsieh, J. J.; Todd Hsu ; Cheung, Y. C. | Lung Cancer | | | |
| 2012 | Erlotinib Treatment in Patients with Advanced Lung Adenocarcinoma with CISH-positive and CISH-negative EGFR Gene Alterations | Hou, M. M.; Huang, S. F.; Kuo, H. P.; Yang, C. T.; Tsai, Y. H.; Yu, C. T.; Lin, H. C.; Chen, C. H.; Wang, C. L.; Chung, F. T.; Hsieh, J. J.; Todd Hsu ; Cheng, H. Y.; Ou, L. Y.; Wang, H. M.; Lin, Y. C.; Chang, N. J.; Chang, J. W. C. | Anticancer Research | | | |
| 2010 | Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma | Hou, M. M.; Hsieh, J. J.; Chang, N. J.; Huang, H. Y.; Wang, H. M.; Chuang, C. K.; Todd Hsu ; Chang, J. W. C. | Clinical Drug Investigation | | | |
